首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Risk assessment of the total testing process based on quality indicators with the Sigma metrics
【24h】

Risk assessment of the total testing process based on quality indicators with the Sigma metrics

机译:基于SIGMA指标的质量指标的总检测过程风险评估

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Evidence-based evaluation of laboratory performances including pre-analytical, analytical and post-analytical stages of the total testing process (TTP) is crucial to ensure patients receiving safe, efficient and effective care. To conduct risk assessment, quality management tools such as Failure Mode and Effect Analysis (FMEA) and the Failure Reporting and Corrective Action System (FRACAS) were constantly used for proactive or reactive analysis, respectively. However, FMEA and FRACAS faced big challenges in determining the scoring scales and failure prioritization in the assessment of real-world cases. Here, we developed a novel strategy, by incorporating Sigma metrics into risk assessment based on quality indicators (QIs) data, to provide a more objective assessment of risks in TTP.
机译:背景:基于证据的实验室性能评估,包括预分析,分析和分析阶段的总测试过程(TTP)至关重要,以确保患者接受安全,有效和有效的护理。 为了进行风险评估,质量管理工具如失败模式和效果分析(FMEA)和故障报告和纠正措施系统(FRACAS)分别用于积极的或反应分析。 然而,FMEA和FRACAS在确定了真实案例评估中的评分尺度和失败优先级方面面临着重大挑战。 在这里,我们通过将SIGMA指标纳入风险评估,基于质量指标(QIS)数据,制定了一种新的策略,为TTP中的风险提供了更客观的评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号